EACR LBx 24 – Combined epitope-independent microfluidic isolation and advanced staining of circulating tumour cells isolated from metastatic prostate cancer blood samples.
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer
DDR Conference – Detection of DNA Damage Response Biomarkers in Circulating Tumour Cells using ANGLE’s Parsortix® instrument and downstream immunofluorescence assays
Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C‑ProMeta‑1)
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
Invadopodia play a role in prostate cancer progression
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
EMT‑independent detection of circulating tumor cells in human blood samples and pre‑clinical mouse models of metastasis
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients